CAS 2307249-33-6

[2-Amino-4-(trifluoromethoxy)phenyl][4-[7-(4-methyl-1-piperazinyl)pyrido[3,2-d]pyrimidin-4-yl]-1-piperidinyl]methanone

CAS : 2307249-33-6

Formule : C₂₅H₂₈F₃N₇O₂

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 515.5307

Ref: IN-DA01EO7A

(2-Amino-4-(Trifluoromethoxy)Phenyl)(4-(7-(4-Methylpiperazin-1-Yl)Pyrido[3,2-D]Pyrimidin-4-Yl)Piperidin-1-Yl)Methanone

CAS : 2307249-33-6

(2-Amino-4-(Trifluoromethoxy)Phenyl)(4-(7-(4-Methylpiperazin-1-Yl)Pyrido[3,2-D]Pyrimidin-4-Yl)Piperidin-1-Yl)Methanone

Degré de pureté : 99+%

Masse moléculaire : 515.53g/mol

Ref: 54-PC108579

BAY885

CAS : 2307249-33-6

BAY885

Degré de pureté : ≥98%

Masse moléculaire : 515.53g/mol

Ref: 54-BUP00452

BAY885

CAS : 2307249-33-6

BAY885 is a new ERK5 inhibitor.

Formule : C₂₅H₂₈F₃N₇O₂

Degré de pureté : 99.83%

Couleur et forme : Solid

Masse moléculaire : 515.53

Ref: TM-T10479

BAY-885

CAS : 2307249-33-6

BAY-885 is a drug development candidate that has been shown to have potent cytotoxic activity against cancer cells. BAY-885 inhibits the constitutive activation of the transcription factor NF-κB, which is involved in tumor growth, proliferation, and survival. It also inhibits the enzymatic activity of the protein caspase 3. This drug has demonstrated high potency in cell culture and animal models.

Formule : C₂₅H₂₈F₃N₇O₂

Degré de pureté : Min. 95%

Masse moléculaire : 515.53 g/mol

Ref: 3D-HSD24933